Co-Administration of GnRH-Agonists with Adjuvant Chemotherapy in Young Breast Cancer Patients: The Effect on Ovarian Function and on Clinical Outcome

被引：0
|
作者：
Goldberg, H.
Stern, M.
Risel, S.
Kuten, A.
Evron, E.
Peretz, T.
Katz, D.
机构：
[1] Western Galilee Hosp, Nahariyya, Israel
[2] Meir Med Ctr, Kefar Sava, Israel
[3] Rabin Med Ctr, Petah Tiqwa, Israel
[4] Rambam Med Ctr, Haifa, Israel
[5] Assaf Harofeh Med Ctr, Zerifin, Israel
[6] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P2-14-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-14-04
引用
收藏
页数：1
相关论文
共 50 条
  • [21] UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy
    Ling Zhang
    Xili Cao
    Liqian Zhang
    Xuelin Zhang
    Haihui Sheng
    Kun Tao
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 629 - 634
  • [22] Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy
    Ismail-Khan, R.
    Minton, S.
    Cox, C.
    Sims, I.
    Lacevic, M.
    Gross-King, M.
    Xu, P.
    Carter, B.
    Munster, P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Dyslipidaemias after adjuvant chemotherapy in young Chinese breast cancer patients
    Yeo, W.
    Mo, F.
    Suen, J.
    Loong, H.
    Pang, E.
    Yip, C.
    Liem, G. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
    Wang, Siyuan
    Pei, Lin
    Hu, Taobo
    Jia, Mei
    Wang, Shu
    HUMAN REPRODUCTION, 2021, 36 (04) : 976 - 986
  • [25] Assessment of the effect of chemotherapy on ovarian function in women with breast cancer
    Anderson, Richard A.
    Cameron, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1630 - 1631
  • [26] GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
    Zhong, Ying
    Lin, Yan
    Cheng, Xinqi
    Huang, Xin
    Zhou, Yidong
    Mao, Feng
    Wang, Yajing
    Guan, Jinghong
    Shen, Songjie
    Xu, Yali
    Peng, Li
    Li, Yan
    Cao, Xi
    Sun, Qiang
    JOURNAL OF CANCER, 2019, 10 (18): : 4278 - 4285
  • [27] EFFECT OF ADJUVANT CHEMOTHERAPY OF BREAST-CANCER ON GONADAL-FUNCTION
    MULLER, H
    ZENTRALBLATT FUR GYNAKOLOGIE, 1990, 112 (13): : 795 - 801
  • [28] Gonadotropin-Releasing Hormone Agonists During Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients With Breast Cancer: A Systematic Review and Meta-Analysis
    Yuan, Yuan
    Zhang, Chu
    Lei, Xueli
    Ren, Tianshu
    Chen, Han
    Zhao, Qingchun
    BREAST CARE, 2023, 18 (04) : 270 - 277
  • [29] Concurrent gonadotropin-releasing hormone (GnRH) agonist administration with chemotherapy improves neoadjuvant chemotherapy responses in young premenopausal breast cancer patients
    Yoon, T. I.
    Kim, H. J.
    Yu, J. H.
    Sohn, G.
    Ko, B. S.
    Lee, J. W.
    Son, B. H.
    Ahn, S. H.
    CANCER RESEARCH, 2016, 76
  • [30] Protection of ovarian function with an LH-RH analogue during chemotherapy in young breast cancer patients
    Ogawa, M.
    Masuda, N.
    Yamamura, J.
    Masuda, H.
    Karita, M.
    Nakamori, S.
    Tsujinaka, T.
    BREAST, 2009, 18 : S66 - S67
12345